HOME >> BIOLOGY >> NEWS
1st International Conference on Cell Therapy for Cardiovascular Disease

The First International Conference on Cell Therapy for Cardiovascular Diseases: A One Day Symposium will consist of a morning and an afternoon session. Presentations will focus on current data in both basic and clinical areas, and will be delivered in a format designed to promote discussion and debate.

During the morning session, local factors that serve to promote or interfere with cell survival will be discussed, followed by a detailed review of cell types under active investigation. This will be followed by a review of cell delivery strategies and methods for evaluating their effects. An open debate over lunch will follow. The afternoon session will consist of a comprehensive review of data from both completed and ongoing clinical trials for both acute and chronic myocardial disease, followed by a question-and-answer session.

The Symposium will bring together the leaders in the field of cardiac myogenesis. It is anticipated that many attendees will have preexisting knowledge of principles, experimental design, and results of completed studies in the field of cell therapy for cardiovascular diseases. A wide cross-section of members of basic and clinical researchers, from academic, industry, and regulatory communities will be in attendance.

Date:
Wednesday, June 16, 2004
8:00 a.m. to 5:00 p.m.

Location:
New York Academy of Medicine
1216 Fifth Avenue
Corner of Fifth Avenue and 103rd Street
New York, NY 10029
Tel: 212-822-7200

Symposium Director:

Warren Sherman, M.D.
Director of Medical Education, Cardiac Catheterization Laboratories
Associate Director, Cardiac Catheterization Laboratories
The Zena and Michael A. Wiener Cardiovascular Institute
The Mount Sinai Hospital, New York

Symposium Co-Directors:

Valentin Fuster, M.D., Ph.D.
Director, The Zena and Michael A. Wiener Cardiovascular Institute and The M
'"/>

Contact: Mount Sinai Press Office
NewsMedia@mssm.edu
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine
10-Jun-2004


Page: 1 2

Related biology news :

1. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
2. USAID, Conservation International & Starbucks launch Conservation Coffee Alliance in Central America
3. ConocoPhillips & Conservation International launch Biodiversity Action Plan in Venezuela
4. A room with a view for the International Space Station: Completion of the cupola observation module
5. International symposium on nutritional genomics
6. First International Scientific Conference on Childhood Leukaemia
7. International research conferences at the Villa Vigoni
8. Conservation International & SC Johnson invest in Ecuadors rainforest to offset climate impacts
9. STN International launches Derwent World Patents Index First View
10. Media invited to attend International Society For Heart & Lung Transplantation meeting April 21-24
11. International critical care doctors release first-ever guidelines for sepsis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/28/2020)... ... , ... CrucialTrak, a global designer and manufacturer of biometric access control systems, ... market and sell its complete line of biometric readers and access gates . ... solutions . , Brett Mason, CrucialTrak’s Director of Channel Sales for the Americas ...
(Date:5/28/2020)... ... May 28, 2020 , ... ... results from their 1801 Phase 1/2 study (NCT03678883, EudraCT #: 2018-003739-32) will be ... will take place virtually on May 29th, 2020. Dr. Benedito Carneiro, Brown University’s ...
(Date:5/21/2020)... ... May 21, 2020 , ... ... in background and medical screening, announces the launch of a testing service ... workforce safe. The new service is provided by ClearStar’s Medical Information Services ...
Breaking Biology News(10 mins):
(Date:5/15/2020)... ... May 14, 2020 , ... ... multiple open heart surgeries before becoming adults. The reason: there are ... address this critical unmet need, the Department of Defense has awarded Draper, Boston ...
(Date:5/15/2020)... ... May 15, 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage ... Ganz as Executive Chairman. Mr. Ganz will continue to lead Sentien’s Board of ... work closely with CEO Brian Miller and Sentien’s management team. , Mr. ...
(Date:5/14/2020)... ... May 12, 2020 , ... NanoString ... bringing together thousands of industry leaders, clinicians, research scientists, medical professionals and academics ... Carl June, MD, Director of the Center for Cellular Immunotherapies at the Perelman ...
(Date:5/14/2020)... ... May 13, 2020 , ... ... phenotypic readouts, providing little or no information on the drug’s mechanism of action ... characterization of compounds by measuring the activity of molecular pathways. This information can ...
Breaking Biology Technology:
Cached News: